CD4 and neoplasm: While IFN-α abrogates the suppressive activity of CD4+ CD25+ Foxp3+ Tregs, thus hampering tumor evasion (35, 36), IFN-I signal blockade boosts the ICB-induced antitumor response by favoring the effector T cells to Tregs ratio (37).